65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79725D0145
- Awardee
-
Fresenius Kabi, LLC UEI C2TRNWNQKMD6
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 1
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 29% complete
- IDV ceiling
- $709,789,232.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Fresenius Kabi, LLC under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on May 15, 2025, with a ceiling value of $709.8 million and ultimate completion date of May 14, 2030. This is a multiple-award catalog vehicle through which federal agencies order injectable pharmaceutical products and biologics from the contractor's price list without conducting new competitions.
The schedule covers drugs, pharmaceuticals, and hematology-related products designated as VA Schedule 65 I B with life cycle to permanent status. Fresenius Kabi supplies injectable medications including ketorolac, diphenhydramine, lidocaine, furosemide, rocuronium, protamine, atropine, dexamethasone, vancomycin, gentamicin, mannitol, methylprednisolone, and propofol in vial and syringe formats. Place of performance is Long Grove, Illinois.
Recent ordering activity reflects the granular medical-supply ordering pattern typical of federal pharmaceutical procurement. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response issued a delivery order on July 30, 2026, with a ceiling value of $7.9 million for atropine 0.4 mg/ml and midazolam 5 mg/ml solutions in multi-dose vials, with ultimate completion July 29, 2027. The Veterans Integrated Service Network 12 is a primary customer under this schedule, with the VA Veterans Health Administration holding $709.8 million combined potential value across this vehicle.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Atropine 0.4MGML x 20ML soln. For INJ., multi-dose vials 8MG and midazolam soln. For INJ., 5MG/ML, multi-dose vials | Office of the Assistant Secretary for Preparedness and Response | $7,878,120 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 42
Quick answers
Who was awarded contract 36F79725D0145?
36F79725D0145 was awarded to Fresenius Kabi, LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on May 15, 2025.
How much is contract 36F79725D0145 worth?
36F79725D0145's own ceiling is $709,789,232.
How many orders have been placed under contract 36F79725D0145?
1 order has been placed under 36F79725D0145, the latest on July 30, 2026.
Who can order from contract 36F79725D0145?
36F79725D0145 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79725D0145 part of a contract vehicle?
Yes. 36F79725D0145 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79725D0145 competed?
The extent of competition for 36F79725D0145 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV